---
schema_version: "secwatch.filing_event.v1"
accession: "0001601485-25-000009"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2025-01-23T23:59:59+00:00"
generated_at: "2026-05-27T14:21:14.087626+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Elicio posts corporate deck; no extractable clinical/financial data in filing text

## Summary
- Corporate presentation posted on company website dated January 23, 2025.
- Presentation title: 'Targeting the Lymph Nodes to AMPlify Immunotherapy'.
- No specific pipeline, financial, or milestone data available from the provided exhibit text.
- Standard forward-looking statement disclaimers and market data cautions included.

## SEC filing metadata
- accession: 0001601485-25-000009
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2025-01-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000160148525000009/0001601485-25-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000160148525000009/angn-20250123.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601485-25-000009
- JSON: https://secwatch.observer/filing/0001601485-25-000009.json
- Plain text: https://secwatch.observer/filing/0001601485-25-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.